DTech Liquidating (DMTKQ) Stock Price

DTech Liquidating Price

NASDAQ·CLOSED
0
​
Market closed

Over the last 4 years DTech Liquidating grew revenue by 46.1% annually, reaching 15.30 M USD. For DTech Liquidating, the net margin of -659.6% is down versus -586.0% a few years ago. Of 8 analysts, 0 rate the stock a buy — an overall Sell consensus.

DTech Liquidating stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

DTech Liquidating business model & stock analysis

DermTech, Inc. develops and sells non-invasive genomics tests for skin disease diagnosis and treatment, focusing on melanoma detection. The company's primary product, the DermTech Melanoma Test (DMT), marketed as Pigmented Lesion Assay (PLA), analyzes skin samples collected via Smart Stickers to identify genomic markers linked to melanoma. Healthcare providers and dermatologists purchase these tests to assess pigmented skin lesions, addressing unmet needs in diagnosing melanoma early. The company's technology enables non-invasive early detection of higher-risk lesions, reducing unnecessary biopsies. DermTech's commercial test targets the diagnostic pathway for pigmented skin lesions, commonly known as moles, which are dark-colored patches of skin. The firm's focus on inflammatory skin diseases and aging-related skin conditions complements its melanoma detection offerings. By enhancing early melanoma detection through genomic analysis, DermTech provides a solution for clinicians managing skin cancer risks without invasive procedures. The company's products are designed to facilitate clinical assessment of skin lesions that raise melanoma concerns, streamlining the diagnostic process. DermTech's approach to non-invasive testing supports healthcare systems by improving efficiency in skin cancer management. The firm's technology specifically addresses genomic markers associated with melanoma, offering a targeted solution for high-risk lesion identification.

Frequently asked questions about DTech Liquidating

8 analysts currently rate the DTech Liquidating stock: 0 recommend buying, 3 holding and 5 selling.

The DTech Liquidating share (DMTKQ) is listed on 1 stock exchanges, including: NASDAQ (DMTK).

The revenue cannot currently be calculated for DTech Liquidating.

The profit cannot currently be calculated for DTech Liquidating.

The P/E ratio cannot be calculated for DTech Liquidating at the moment.

The P/S cannot be calculated for DTech Liquidating currently.

The Eulerpool Quality Score for DTech Liquidating is 4/10.

The ISIN of DTech Liquidating is US24984K1051. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of DTech Liquidating is DMTKQ. The ticker symbol is used to trade DTech Liquidating shares on the stock exchange.

Fair ValueTerminal
148.30 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Biotechnology
Number of shares
Employees
Revenue per Employee
55,021.58 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website dermtech.com
Currency
USD
Initial public offering
Jun 20, 2017
ISIN
US24984K1051
Cusip
24984K105
Market capitalization
52-Week Range
PEG
—
P/E ratio
P/Ee 2024
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
—
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-176.29 %
Last updated Nov 21, 2026, 9:01 PM

DTech Liquidating Peer Group

DTech Liquidating Ticker

NASDAQ · DMTK

DTech Liquidating FIGI

DMTK:US · BBG00H19F184DMTK:UA · BBG00HDL5K74DMTK:UN · BBG00HDL5K92DMTK:UP · BBG00HDL5KB9DMTK:UB · BBG00HDL5KD7DMTK:UM · BBG00HDL5KG4DMTK:UX · BBG00HDL5KH3DMTK:UR · BBG00HDL5KJ1DMTK:UD · BBG00HDL5KN6DMTK:UF · BBG00HDL5KR2DMTK:VY · BBG00HDL5KS1DMTK:VJ · BBG00HDL5KT0

All fundamentals and in-depth analysis of DTech Liquidating

Our stock analysis for DTech Liquidating stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of DTech Liquidating. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.